Clinical Trials Directory

Trials / Conditions / Ann Arbor Stage IV Grade 3 Follicular Lymphoma

Ann Arbor Stage IV Grade 3 Follicular Lymphoma

6 registered clinical trials studyying Ann Arbor Stage IV Grade 3 Follicular Lymphoma.

StatusTrialSponsorPhase
Active Not RecruitingALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma
NCT05025800
M.D. Anderson Cancer CenterPhase 1 / Phase 2
Active Not RecruitingAcalabrutinib, Lenalidomide, and Rituximab for the Treatment of CD20 Positive Stage III-IV, Grade 1-3a Follicu
NCT04404088
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingRituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular L
NCT01829568
National Cancer Institute (NCI)Phase 1
CompletedOfatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Folli
NCT01286272
National Cancer Institute (NCI)Phase 2
CompletedVorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-C
NCT01193842
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedLenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Fol
NCT01145495
National Cancer Institute (NCI)Phase 2